Publicaciones en colaboración con investigadores/as de Hospital de Poniente (20)

2022

  1. T2 Biomarkers as Predictors of Exacerbations of Chronic Obstructive Pulmonary Disease

    Archivos de Bronconeumologia, Vol. 58, Núm. 8, pp. 595-600

2021

  1. COPD Diagnosis in EPI-SCAN II

    Archivos de Bronconeumologia

  2. Microspirometers in the Follow-Up of COPD: Advantages and Disadvantages

    Archivos de Bronconeumologia

2020

  1. Management and Follow up of Respiratory Patients in the Post-COVID-19 Era: Are We Ready Yet?

    Archivos de Bronconeumologia

  2. Personalized Medicine in Chronic Obstructive Pulmonary Disease: How Close Are We?

    Archivos de Bronconeumologia, Vol. 56, Núm. 7, pp. 420-421

  3. Relationship between clinical control, respiratory symptoms and quality of life for patients with COPD

    International Journal of COPD, Vol. 15, pp. 2683-2693

  4. SARS-CoV-2 Infection in Patients with Lung Cancer: Current Clinical Context

    Archivos de Bronconeumologia

  5. Small cell lung cancer: Recent changes in clinical presentation and prognosis

    Clinical Respiratory Journal, Vol. 14, Núm. 3, pp. 222-227

2019

  1. Liquid biopsy beyond of cancer: Circulating pulmonary cells as biomarkers of COPD aggressivity

    Critical Reviews in Oncology/Hematology, Vol. 136, pp. 31-36

  2. The Use of Non-Tumor-Related Liquid Biopsy in Respiratory Medicine

    Archivos de Bronconeumologia, Vol. 55, Núm. 11, pp. 555-556

2018

  1. Alveolar and Bronchial Nitric Oxide in Chronic Obstructive Pulmonary Disease and Asthma-COPD Overlap

    Archivos de Bronconeumologia, Vol. 54, Núm. 8, pp. 414-419

  2. Changes in non-small cell lung cancer diagnosis, molecular testing and prognosis 2011-2016

    Journal of Thoracic Disease, Vol. 10, Núm. 9, pp. 5468-5475

  3. Clinical Guidelines in Asthma and Chronic Obstructive Pulmonary Disease: How Useful Are They in Clinical Practice?

    Archivos de Bronconeumologia, Vol. 54, Núm. 3, pp. 117-118

  4. Factors affecting the selection of an inhaler device for COPD and the ideal device for different patient profiles. Results of EPOCA Delphi consensus

    Pulmonary Pharmacology and Therapeutics, Vol. 48, pp. 97-103

  5. Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD

    European Respiratory Journal, Vol. 51, Núm. 1

  6. The Future of Triple Therapy in chronic obstructive pulmonary disease

    Archivos de Bronconeumologia, Vol. 54, Núm. 2, pp. 63-64

2017

  1. A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease

    Respiratory Research, Vol. 18, Núm. 1

  2. Requirements, Strengths and Weaknesses of Inhaler Devices for COPD Patients from the Expert Prescribers' Point of View: Results of the EPOCA Delphi Consensus

    COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 14, Núm. 6, pp. 573-580

2016

  1. Evaluation of symptomatic patients without airflow obstruction: Back to the future

    Journal of Thoracic Disease

2015

  1. «Correct Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease»: A Consensus Document

    Archivos de Bronconeumologia, Vol. 51, Núm. 4, pp. 193-198